BioTech

EGenesis Lands $100M to Advance CRISPR-ed Pig Kidney to Human Test

6 monthes ago   |   By Xconomy

Biotech startup eGenesis, which is applying gene editing to animal organs in order to make them suitable for human transplant, has raised $100 million to ramp work on its kidney program and bring it into human testing. The Series B round of funding was led by the investment arm of Fresenius Medical Care Ventures, a German company that provides kidney dialysis services. Cambridge, MA-based eGenesis says that in addition to supporting its kidney program, the new capital will support its other research into xenotransplantation-the transplant of animal organs into humans. The company's progams...
Read more ...

 


Search by Tags

   BioTech      Biotech      Animals      Gene      Research      Genes      Applied      Boston      Boston blog main      Boston top stories      National blog main      Alta Partners      ARCH Venture Partners      Biomatics Capital      CRISPR      Deals      EGenesis      Fresenius Medical Care      Gene editing      George Church      Harvard University      Investing      Khosla Ventures      Life Sciences      Lung Biotechnology      Startups      Xenotransplantation  


World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

Webinar: Using SMRT Sequencing to Understand SARS-CoV-2 and the Host Immune...

Webinar: Using SMRT Sequencing to Understand SARS-CoV-2 and the Host Immune Response

As the flurry of research around the SARS-CoV-2 virus continues at an unprecedented pace, scientists are beginning to tackle some of the more complex immunological responses... Read more ...

Regeneron Pays Intellia $100M to Add Hemophilia to CRISPR R&D Pact

Regeneron Pays Intellia $100M to Add Hemophilia to CRISPR R&D Pact

Four years after Regeneron Pharmaceuticals and Intellia Therapeutics began working together to research the use of CRISPR/Cas9 to treat liver diseases, the partners are... Read more ...

Marketing Coordinator - Advin Biotech - Sorrento, CA

Advin Biotech is a growing medical diagnostics company looking for a creative individual skilled in social media engagement;From Advin Biotech - Tue, 02 Jun 2020 08:54:25 GMT... Read more ...

Gene found that causes eyes to wither in cavefish

Mexican cavefish spend their entire lives in the dark. With no need for vision, many of them lost functional eyes. In more than 30 varieties of Mexican cavefish, the eyes stop... Read more ...

AnaptysBio, Inc.: Facilities Manager

AnaptysBio, Inc.: The Facilities Manager plays a key role ensuring all facilities and equipment support the Company's operations. This person oversees the daily operati San... Read more ...

Research Technician I

Position Overview San Diego Biomedical Research Institute has an opportunity immediately available for a full-time, benefits eligible Research Technician I position. The... Read more ...

Now Complete, Telescope Instrument is Poised to Begin Its Search for Answers...

This video contains animations showing how the complex components of the Dark Energy Spectroscopic Instrument, installed on the Mayall Telescope at Kitt Peak National... Read more ...

Your Brain Needs to Be Ready to Remember?

Read more ...

New Biosensor Visualizes Stress in Living Plant Cells in Real Time

Read more ...

104735 Clinical Trials Coordinator

RADIOLOGY Salary commensurate with qualifications and experienceFiling Deadline: Mon 6/15/2020... Read more ...